KUALA LUMPUR, Jan 4 (Bernama) -- Enovis Corporation (Enovis) announced it has closed the acquisition of LimaCorporate S.p.A. (Lima), a privately held global orthopaedic leader focused on restoring motion through an innovative portfolio of implant solutions.
“We are excited to welcome Lima's talented team to Enovis. The combination brings Enovis’ recon segment to US$1 billion in revenues and creates a fast-growing innovator in the global orthopaedic reconstruction market. (US$1=RM4.64)
“This is another great example of how we use strategic acquisitions to accelerate our growth, add great technologies and talent to our company, and drive compounding value for our shareholders,” said Enovis Chair and Chief Executive Officer, Matt Trerotola.
According to a statement, Lima strengthens Enovis’ position in the global orthopaedic reconstruction market with a complementary portfolio of proven surgical solutions and technologies, which will accelerate global growth and margin expansion.
In addition, Lima's portfolio includes 3D printed Trabecular Titanium implants and a comprehensive revision offering in shoulders, which will further strengthen Enovis’ position in the fast-growing extremities market.
Enovis is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows.
-- BERNAMA
No comments:
Post a Comment